Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ozturk MA et al. | Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit. | 2006 | Mycoses | pmid:17022766 |
| Mousa HA and al-Bader SM | Yeast infection of burns. | 2001 | Mycoses | pmid:11486451 |
| Auger P et al. | Treatment of cutaneous candidosis in guinea pigs: effect of zinc oxide on the antifungal efficacy of nystatin. | 1989 | Mycoses | pmid:2608092 |
| Boon JM et al. | Comparison of ketoconazole suspension and nystatin in the treatment of newborns and infants with oral candidosis. | 1989 | Mycoses | pmid:2779612 |
| Sharifzadeh A et al. | Evaluation of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel (Camelus dromedarius) genital tract. | 2015 | Mycoses | pmid:26152466 |
| FEINGOLD DS | ANTIMICROBIAL CHEMOTHERAPEUTIC AGENTS: THE NATURE OF THEIR ACTION AND SELECTIVE TOXICITY. | 1963 | N. Engl. J. Med. | pmid:14050990 |
| Dismukes WE et al. | A randomized, double-blind trial of nystatin therapy for the candidiasis hypersensitivity syndrome. | 1990 | N. Engl. J. Med. | pmid:2247104 |
| Bennett JE | Searching for the yeast connection. | 1990 | N. Engl. J. Med. | pmid:2247107 |
| Casalaz D | Fluconazole prophylaxis against fungal infection in preterm infants. | 2002 | N. Engl. J. Med. | pmid:12066811 |
| A controlled trial of nystatin for the candidiasis hypersensitivity syndrome. | 1991 | N. Engl. J. Med. | pmid:2027363 | |
| Wade JC et al. | A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. | 1981 | N. Engl. J. Med. | pmid:6782486 |
| Bhattacharya S et al. | DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. | 2012 | Nano Lett. | pmid:22375622 |
| Al-Jubory AR and Handy RD | Uptake of titanium from TiOâ‚‚ nanoparticle exposure in the isolated perfused intestine of rainbow trout: nystatin, vanadate and novel COâ‚‚-sensitive components. | 2013 | Nanotoxicology | pmid:23020080 |
| Marmiroli M et al. | A genome-wide nanotoxicology screen of Saccharomyces cerevisiae mutants reveals the basis for cadmium sulphide quantum dot tolerance and sensitivity. | 2016 | Nanotoxicology | pmid:25938282 |
| Wang MM et al. | Mutagenicity of ZnO nanoparticles in mammalian cells: Role of physicochemical transformations under the aging process. | 2015 | Nanotoxicology | pmid:25676621 |
| Shi L et al. | Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels. | 2013 | Nat Commun | pmid:23385580 |
| Gerstein AC et al. | Loss-of-heterozygosity facilitates passage through Haldane's sieve for Saccharomyces cerevisiae undergoing adaptation. | 2014 | Nat Commun | pmid:24804896 |
| Anderson HA et al. | Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. | 2000 | Nat. Immunol. | pmid:11248809 |
| Grassmé H et al. | Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. | 2003 | Nat. Med. | pmid:12563314 |
| Khan A et al. | A new triterpenoid from roots of Laportea crenulata and its antifungal activity. | 2007 | Nat. Prod. Res. | pmid:17691044 |